









journal of nuclear medicine












































skip to main content




 
















 






 
 










main menu






home 
content current
ahead of print
past issues
jnm supplement
snmmi annual meeting abstracts
continuing education
jnm podcasts

subscriptions subscribers
institutional and non-member
rates
journal claims
corporate & special sales

authors submit to jnm
information for authors
assignment of copyright
aqara requirements

info reviewers
permissions
advertisers

about about us
editorial board
contact information

more alerts
feedback
help
snmmi journals







snmmijnm
jnmt
snmmi journals
snmmi










user menu






subscribe
my alerts
log in
log out
 my cart





 



 







search






search for this keyword 




 




advanced search
 


















 






 
 







snmmijnm
jnmt
snmmi journals
snmmi




 









 



subscribe
my alerts
log in
log out
 my cart
 






 
 






 






















search for this keyword 




 



advanced search 











select languageenglishafrikaansalbanianamharicarabicarmenianazerbaijanibasquebelarusianbengalibosnianbulgariancatalancebuanochichewachinese (simplified)chinese (traditional)corsicancroatianczechdanishdutchesperantoestonianfilipinofinnishfrenchfrisiangaliciangeorgiangermangreekgujaratihaitian creolehausahawaiianhebrewhindihmonghungarianicelandicigboindonesianirishitalianjapanesejavanesekannadakazakhkhmerkoreankurdish (kurmanji)kyrgyzlaolatinlatvianlithuanianluxembourgishmacedonianmalagasymalaymalayalammaltesemaorimarathimongolianmyanmar (burmese)nepalinorwegianpashtopersianpolishportuguesepunjabiromanianrussiansamoanscottish gaelicserbiansesothoshonasindhisinhalaslovaksloveniansomalispanishsudaneseswahiliswedishtajiktamilteluguthaiturkishukrainianurduuzbekvietnamesewelshxhosayiddishyorubazulu 

 
 






home 
content current
ahead of print
past issues
jnm supplement
snmmi annual meeting abstracts
continuing education
jnm podcasts

subscriptions subscribers
institutional and non-member
rates
journal claims
corporate & special sales

authors submit to jnm
information for authors
assignment of copyright
aqara requirements

info reviewers
permissions
advertisers

about about us
editorial board
contact information

more alerts
feedback
help
snmmi journals







 view or listen to jnm podcast
 visit jnm on facebook
 join jnm on linkedin
 follow jnm on twitter
 subscribe to our rss feeds
 

 





















services claiming to be jnm are soliciting authors, editors, and reviewers. read more to protect yourself.







 











 






















jnm podcast episode 8 – revolutionizing cardiovascular imaging with flurpiridaz 
















177lu-dotatate plus capecitabine versus 177lu-dotatate alone in patients with advanced grade 1/2 gastroenteropancreatic neuroendocrine tumors (lucap): a randomized, phase 2 trial 
















radioflow cytometry reveals that [18f]fdg uptake in k-ras lung cancer is driven by immune cells: an analysis on a single-cell level 
















entities are misrepresenting themselves as jnm. read more on how to protect yourself. 












  
1 

2 

3 

4 
 
 
 






published ahead of print





you have access
[18f]mk-6240 radioligand delivery indices as surrogates of cerebral perfusion: bias and correlation against [15o]water
jessie fanglu fu, meher r. juttukonda, arun garimella, andrew n. salvatore, cristina lois, anthony ranasinghe, nikos efthimiou, hasan sari, william aye, nicolas j. guehl, georges el fakhri, keith a. johnson, bradford c. dickerson, david izquierdo-garcia, ciprian catana and julie c. price
journal of nuclear medicine february 13, 2025, jnumed.124.268701; doi: https://doi.org/10.2967/jnumed.124.268701 



you have access
reply: a comment on “effectiveness and patient experiences of rhenium skin cancer therapy for nonmelanoma skin cancer: interim results from the epic-skin study”
gerhard dahlhoff
journal of nuclear medicine february 13, 2025, jnumed.124.269115; doi: https://doi.org/10.2967/jnumed.124.269115 




you have access
full-body tumor response heterogeneity of metastatic neuroendocrine tumor patients undergoing peptide receptor radiopharmaceutical therapy
victor santoro-fernandes, brayden schott, amy j. weisman, ojaswita lokre, steve y. cho, scott b. perlman, timothy g. perk and robert jeraj
journal of nuclear medicine february 13, 2025, jnumed.124.267809; doi: https://doi.org/10.2967/jnumed.124.267809 




you have access
68ga-fapi-04 pet/ct imaging for assessing renal tubulointerstitial fibrosis in lupus nephritis
shuyi yu, zhixia yang, zetao ding, yingqi jia, liyan wan, lei li, jing lv, haoyu pan, jinyi qian, xiaohan wei, yue yang, yunlong zan, jialin teng, biao li, chengde yang, jing xu, luan xue, hui shi and min zhang
journal of nuclear medicine february 13, 2025, jnumed.124.268643; doi: https://doi.org/10.2967/jnumed.124.268643 




you have access
pilot study of nectin-4–targeted pet imaging agent 68ga-fz-nr-1 in triple-negative breast cancer from bench to first-in-human
li sun, yuyun sun, ke zuo, lei fan, xiao wang, jianping zhang, silong hu, xiaosheng liu, jindian li, ye li, zhiming shao, xiaoping xu, aiguo wu and shaoli song
journal of nuclear medicine february 13, 2025, jnumed.124.269024; doi: https://doi.org/10.2967/jnumed.124.269024 



you have access
176lu radiation dose of long–axial field of view pet scanners
samaneh mostafapour, joyce van sluis, adriaan a. lammertsma and charalampos tsoumpas
journal of nuclear medicine february 13, 2025, jnumed.124.269187; doi: https://doi.org/10.2967/jnumed.124.269187 


 


view more published ahead of print articles
 
 







featured articles







 177lu-dotatate plus capecitabine versus 177lu-dotatate alone in patients with... 
  february 03, 2025 

 radioflow cytometry reveals that [18f]fdg uptake in k-ras lung cancer is driven by... 
  february 03, 2025 

 from scientist to analyst to strategist 
  february 03, 2025 

 dosimetry software for theranostic applications: current capabilities and future prospects 
  february 03, 2025 

 large language models and large multimodal models in medical imaging: a primer for physicians 
  february 03, 2025 

 is the clinical implementation of in-house artificial intelligence–developed algorithms happening? 
  february 03, 2025 

 diagnostic radiopharmaceuticals: a sustainable path to the improvement of patient care 
  february 03, 2025 





 


about the journal of nuclear medicine



the journal of nuclear medicine (jnm)—self-published by the society of nuclear medicine and molecular imaging (snmmi), a nonprofit, international scientific and professional organization—offers readers around the globe clinical investigations, basic science reports, continuing education articles, book reviews, employment opportunities, and updates on rapidly changing issues in practice and research.










current issue








journal of nuclear medicine
vol. 66, issue 2 february 1, 2025 
table of contentstable of contents (pdf)about the coverindex by authorcomplete issue (pdf)

 


issue highlights


177lu-dotatate plus capecitabine versus 177lu-dotatate alone in patients with advanced grade 1/2 gastroenteropancreatic neuroendocrine tumors (lucap): a randomized, phase 2 trial


radioflow cytometry reveals that [18f]fdg uptake in k-ras lung cancer is driven by immune cells: an analysis on a single-cell level

 
















 












most citedmost read 








177lu-psma spect quantitation at 6 weeks (dose 2) predicts short progression-free survival for patients undergoing 177lu-psma-i&t therapy


fibroblast-activation protein pet and histopathology in a single-center database of 324 patients and 21 tumor entities


mird pamphlet no. 28, part 1: mirdcalc—a software tool for medical internal radiation dosimetry


unspecific 18f-psma-1007 bone uptake evaluated through psma-11 pet, bone scanning, and mri triple validation in patients with biochemical recurrence of prostate cancer


toward single-time-point image-based dosimetry of 177lu-psma-617 therapy

more... 




 
















 
















 









 





 back to top 




 














 






 
 












 





© 2025 journal of nuclear medicine 





 






 
 
  









